Pharmafile Logo
Pharmafocus logo
Advanced Search
shutterstock_95714119

US hospital’s ketamine study forced to a halt over consent concerns

June 27, 2018
Research and Development Hennepin Healthcare, Ketamine, pharma

Minneapolis-based hospital Hennepin County Medical Center has put the brakes on a clinical trial investigating the efficacy of ketamine in …

News
abbvie_0

Abbvie and Google’s Calico extend age-related disease partnership to $2.5bn

June 27, 2018
Research and Development, Sales and Marketing AbbVie, Cancer, Goggle, calico, pharma

The partnership of Abbvie and Google’s Calico has announced they are to extend their existing 10-year drug discovery and development …

News
astrazeneca_building_white

AstraZeneca’s Lynparza proves efficacy in first-line BRCA-mutated advanced ovarian cancer

June 27, 2018
Research and Development, Sales and Marketing AstraZeneca, Cancer, MSD, Merck, ovarian cancer, pharma

AstraZeneca is celebrating alongside partner MSD with the reveal of new data on the use of Lynparza in the first-line …

News
fdaoutsideweb

FDA panels vote to reject Pain Therapeutics’ abuse-deterrent opioid drug

June 27, 2018
Research and Development, Sales and Marketing Remoxy, opioid crisis, opioids, pain therapeutics, pharma

Drug development firm Pain Therapeutics has revealed that its abuse-deterrent opioid medication Remoxy has been rejected by an FDA advisory …

News
image_credit_roivant

Roivant launches two new companies amid major restructure and staff layoffs

June 26, 2018
Manufacturing and Production, Research and Development Roivant, pharma

Roivant, the global biopharmaceutical firm spearheaded by founder and CEO Vivek Ramaswamy (pictured), has announced it is to undergo a …

News
bi_microparts_image

Boehringer injects €230 million in new Biologicals Development Center

June 26, 2018
Manufacturing and Production Boehringer Ingelheim, biologics, manufacturing, pharma

Prominent industry player Boehringer Ingelheim has unveiled plans to invest €230 million into the construction of a new Biologicals Development …

News
save_our_nhs

NHS “below average” in treating eight most common causes of death, report says

June 26, 2018
Manufacturing and Production, Medical Communications NHS, pharma

The NHS’s 70th birthday is again marked as a bittersweet one as a new report from the Nuffield Trust highlights …

News
pfizerbrussels_web

Pfizer’s Ibrance combo fails to improve overall survival in HER2- metastatic breast cancer

June 26, 2018
Manufacturing and Production, Research and Development, Sales and Marketing AstraZeneca, Faslodex, Pfizer, breast cancer, ibrance, pharma

Pfizer has stumbled with the reveal of new data on the efficacy of its oral CDK 4/6 inhibitor Ibrance (palbociclib) in combination …

News

Sanofi’s Toujeo proves non-inferior to insulin degludec in type 2 diabetes

June 26, 2018
Manufacturing and Production, Research and Development, Sales and Marketing American Diabetes Association, Sanofi, diabetes, insulin glargine, pharma, toujeo, type 2 diabetes

Sanofi took the opportunity at the American Diabetes Association (ADA) 78th Scientific Sessions in Florida to unveil new data on …

News
gwpharma

GW Pharma’s Epidiolex becomes first cannabis-based medicine available in US

June 26, 2018
Manufacturing and Production, Sales and Marketing FDA, GW Pharma, Lennox-Gastaut syndrome, UK, US, cannabidiol, cannabis

In what could prove to be a pivotal decision, UK biotech GW Pharmaceuticals has announced that its oral cannabidiol solution …

News
si_lem_new_photo_171118

Working Life: Vertex Pharma’s Simon Lem, VP, Regional General Manager of North Europe

June 25, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Vertex, Vertex pahrma, Working Life, feature, pharma

Pharmafocus caught up with Vertex Pharma’s Simon Lem to discuss his journey throughout the industry and the importance of the …

Feature
gilead-sciences

European Commission greenlights Gilead’s Biktarvy for HIV-1

June 25, 2018
Sales and Marketing Biktarvy, EU, Europe, European Commission, HIV, HIV-1, pharma

Good news for Gilead and HIV patients across the European Union today as the prominent pharma firm announced that its …

News
shutterstock_349943306

Sophiris halts cancer study after patient death

June 25, 2018
Research and Development, Sales and Marketing Cancer, Sophiris, pharma, prostate cancer

Another clinical trial has been forced to a standstill as biotech firm Sophiris revealed that a patient death had prompted …

News
lilly_entrance_web

Eli Lilly’s dulaglutide doses show blood control and weight benefits at Phase 2

June 25, 2018
Research and Development, Sales and Marketing Eli Lilly, Trulicity, diabetes, pharma

Eli Lilly has announced new data on its once-weekly, injectable glucagon-like peptide Trulicity (dulaglutide 1.5mg) and investigational 3.0 and 4.5mg …

News
sandi_peterson

J&J’s second-in-command to retire, alongside executive restructure

June 25, 2018
Medical Communications, Sales and Marketing J&J, JJ, Johnson & Johnson, pharma

Johnson & Johnson’s Group Worldwide Chairman Sandra Peterson (pictured) has announced she is to retire from her role and the …

News
roche__tree

Roche’s Tecentriq combo extends life in untreated lung cancer

June 25, 2018
Research and Development, Sales and Marketing Cancer, Roche, lung cancer, pharma, tecentriq

Roche has unveiled new data on the efficacy of Tecentriq (atezolizumab) in combination with chemotherapy (carboplatin and etoposide) for the …

News
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

June 22, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing pharma, top ten

The sun is out in the UK, it’s Friday, and the July/August issue of Pharmafocus is going to print. And, …

News

NICE backs Sanofi’s new treatment for atopic dermatitis

June 22, 2018
Medical Communications, Sales and Marketing England, NICE, Sanofi, UK, atopic dermatitis, pharma

NICE has published a positive Final Appraisal Determination FAD recommending dupilumab, in combination with topical corticosteroids, for use on the …

News
fda2outsideweb

FDA approves first continuous glucose monitoring system

June 22, 2018
Medical Communications, Sales and Marketing FDA, diabetes, pharma

The US Food and Drug Administration (FDA) has approved the Eversense Continuous Glucose Monitoring (CGM) system for use in people …

News
astrazeneca_sign_sky

AstraZeneca’s Imfinzi becomes India’s first available immunotherapy for lung cancer

June 22, 2018
Medical Communications, Sales and Marketing AstraZeneca, Imfinzi, India, NSCLC, lung cancer, pharma

In a big step forward for India as AstraZeneca announces that its checkpoint inhibitor Imfinzi (durvalumab) has secured approval in …

News
The Gateway to Local Adoption Series

Latest content

Astellas Pharma’s Vyloy accepted by Scottish Medicines Consortium for gastric cancer

February 4, 2026

Angelini Pharma appoints Sergio Marullo di Condojanni as CEO

February 4, 2026

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026

Alvotech appoints Lisa Graver as CEO

February 3, 2026

HonorHealth Research Institute announces first patient dosed with new stroke treatment

February 2, 2026